126 related articles for article (PubMed ID: 38112281)
1. The impact of comorbidities and sociodemographic predictors on pneumococcal vaccination coverage in adults with coronary heart disease.
Allihien SM; Ibrahim S; Markson F; Agyeman WY; Fugar S; Kesiena O
Future Cardiol; 2024 Jan; 20(1):11-19. PubMed ID: 38112281
[No Abstract] [Full Text] [Related]
2. Pneumococcal vaccination coverage and adherence to recommended dosing schedules in adults: a repeated cross-sectional study of the INTEGO morbidity registry.
Janssens A; Vaes B; Abels C; Crèvecoeur J; Mamouris P; Merckx B; Libin P; Van Pottelbergh G; Neyens T
BMC Public Health; 2023 Jun; 23(1):1104. PubMed ID: 37286969
[TBL] [Abstract][Full Text] [Related]
3. Pneumococcal and influenza vaccination coverage among at-risk adults: A 5-year French national observational study.
Wyplosz B; Fernandes J; Sultan A; Roche N; Roubille F; Loubet P; Fougère B; Moulin B; Duhot D; Vainchtock A; Raguideau F; Lortet-Tieulent J; Blanc E; Moïsi J; Goussiaume G
Vaccine; 2022 Aug; 40(33):4911-4921. PubMed ID: 35811205
[TBL] [Abstract][Full Text] [Related]
4. Pneumococcal Vaccine Coverage in Adults Aged 19-64 Years, Newly Diagnosed With Chronic Conditions in the U.S.
Petigara T; Zhang D
Am J Prev Med; 2018 May; 54(5):630-636. PubMed ID: 29551328
[TBL] [Abstract][Full Text] [Related]
5. Predictors of uptake of newly introduced vaccines in Malawi - monovalent human rotavirus and pneumococcal conjugate vaccines: Evidence from the 2015-16 Malawi demographic and health survey.
Ntenda PAM; Mwenyenkulu ET; Putthanachote N; Nkoka O; Mhone TG; Motsa MPS; Tizifa T
J Trop Pediatr; 2019 Jun; 65(3):287-296. PubMed ID: 30085260
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological characteristics associated with uptake of pneumococcal vaccine among older adults living in the community in Singapore: Results from the National Health Surveillance Survey 2013.
Ang LW; Cutter J; James L; Goh KT
Scand J Public Health; 2018 Mar; 46(2):175-181. PubMed ID: 28701087
[TBL] [Abstract][Full Text] [Related]
7. Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.
Lu PJ; Hung MC; Srivastav A; Grohskopf LA; Kobayashi M; Harris AM; Dooling KL; Markowitz LE; Rodriguez-Lainz A; Williams WW
MMWR Surveill Summ; 2021 May; 70(3):1-26. PubMed ID: 33983910
[TBL] [Abstract][Full Text] [Related]
8. [Risk of pneumococcal disease in elderly patients with and without previous vaccination].
Flores-Copete M; Reolid-Martínez R; López-García M; Alcantud-Lozano P; Mudarra-Tercero E; Azorín-Ras M; Del Campo-Giménez M; Ayuso-Raya MC; Escobar-Rabadán F
Aten Primaria; 2019 Nov; 51(9):571-578. PubMed ID: 30391017
[TBL] [Abstract][Full Text] [Related]
9. Pneumococcal vaccination coverage among US adults enrolled in Medicaid and newly diagnosed with underlying medical conditions.
Liu J; Johnson KD; Shoener Dunham L
Expert Rev Vaccines; 2023; 22(1):596-607. PubMed ID: 37401893
[TBL] [Abstract][Full Text] [Related]
10. Vaccination coverage with the pneumococcal and influenza vaccine among persons with chronic diseases in Shanghai, China, 2017.
Wang Y; Cheng M; Wang S; Wu F; Yan Q; Yang Q; Li Y; Guo X; Fu C; Shi Y; Wagner AL; Boulton ML
BMC Public Health; 2020 Mar; 20(1):359. PubMed ID: 32188428
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of pneumococcal and influenza vaccination coverage in rheumatology patients receiving biological therapy in a regional referral hospital.
Fernández-Prada M; Brandy-García AM; Rodríguez-Fonseca OD; Huerta-González I; Fernández-Noval F; Martínez-Ortega C
Reumatol Clin (Engl Ed); 2020; 16(2 Pt 1):97-102. PubMed ID: 29752214
[TBL] [Abstract][Full Text] [Related]
12. Pneumococcal vaccination coverages by age, sex and specific underlying risk conditions among middle-aged and older adults in Catalonia, Spain, 2017.
Vila-Córcoles A; Ochoa-Gondar O; de Diego C; Satué E; Vila-Rovira A; Aragón M
Euro Surveill; 2019 Jul; 24(29):. PubMed ID: 31339099
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal vaccine uptake among high-risk adults and children in Italy: results from the OBVIOUS project survey.
Di Valerio Z; La Fauci G; Scognamiglio F; Salussolia A; Montalti M; Capodici A; Fantini MP; Odone A; Costantino C; Soldà G; Larson HJ; Leask J; Lenzi J; Gori D;
BMC Public Health; 2024 Mar; 24(1):736. PubMed ID: 38454392
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with pneumococcal vaccination in 2040 people with type 2 diabetes: A cross-sectional study.
Gilani F; Majumdar SR; Johnson JA; Simpson SH;
Diabetes Metab; 2020 Apr; 46(2):137-143. PubMed ID: 31255692
[TBL] [Abstract][Full Text] [Related]
15. Pneumococcal polysaccharide vaccination among adults aged 65 years and older, U.S., 1989-2008.
Lu PJ; Nuorti JP
Am J Prev Med; 2010 Oct; 39(4):287-95. PubMed ID: 20837278
[TBL] [Abstract][Full Text] [Related]
16. Pneumococcal vaccination coverage in France by general practitioners in adults with a high risk of pneumococcal disease.
Kopp A; Mangin O; Gantzer L; Lekens B; Simoneau G; Ravelomanantsoa M; Evans J; Bergmann JF; Sellier P
Hum Vaccin Immunother; 2021 Jan; 17(1):162-169. PubMed ID: 32429734
[No Abstract] [Full Text] [Related]
17. The impact on vaccination coverage following introduction of a routine pneumococcal vaccination programme for the elderly in Japan.
Shono A; Hoshi SL; Kondo M
Vaccine; 2018 Sep; 36(39):5886-5890. PubMed ID: 30143271
[TBL] [Abstract][Full Text] [Related]
18. Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60.
Betsch C; Rossmann C; Pletz MW; Vollmar HC; Freytag A; Wichmann O; Hanke R; Hanke W; Heinemeier D; Schmid P; Eitze S; Weber W; Reinhardt A; Küpke NK; Forstner C; Fleischmann-Struzek C; Mikolajetz A; Römhild J; Neufeind J; Rieck T; Suchecka K; Reinhart K
BMC Public Health; 2018 Jul; 18(1):885. PubMed ID: 30012141
[TBL] [Abstract][Full Text] [Related]
19. Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United States.
McLaughlin JM; Swerdlow DL; Khan F; Will O; Curry A; Snow V; Isturiz RE; Jodar L
Hum Vaccin Immunother; 2019; 15(4):841-849. PubMed ID: 30676236
[TBL] [Abstract][Full Text] [Related]
20. Invasive pneumococcal disease, comorbidities, and polysaccharide vaccine use in children aged 5-15 years in England and Wales.
Ladhani SN; Andrews NJ; Waight P; Borrow R; Slack MP; Miller E
Clin Infect Dis; 2014 Feb; 58(4):517-25. PubMed ID: 24300040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
